Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asoprisnil with Estrogen in Postmenopausal Women
NCT00152282Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Sep 2000
- Primary completion
- Aug 2001
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of asoprisnil in endometrial hyperplasia (EH), postmenopause, sponsored by Abbott Laboratories. Started Sep 2000; status: completed.
02
Drugs
asoprisnil
03
Conditions
endometrial hyperplasia (EH)postmenopause
Beyond the preview
Go deeper on NCT00152282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00152282.